Cell Biotech Co., Ltd.

KOSDAQ:A049960 Stock Report

Market Cap: ₩106.4b

Cell Biotech Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Myung-Jun Jung

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership25.4%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Analysis Article • May 24

Cell Biotech's (KOSDAQ:049960) Weak Earnings May Only Reveal A Part Of The Whole Picture

A lackluster earnings announcement from Cell Biotech Co., Ltd. ( KOSDAQ:049960 ) last week didn't sink the stock price...
Analysis Article • Nov 21

Cell Biotech's (KOSDAQ:049960) Solid Earnings May Rest On Weak Foundations

The recent earnings posted by Cell Biotech Co., Ltd. ( KOSDAQ:049960 ) were solid, but the stock didn't move as much as...
Analysis Article • Nov 09

Cell Biotech (KOSDAQ:049960) Has Affirmed Its Dividend Of ₩450.00

Cell Biotech Co., Ltd.'s ( KOSDAQ:049960 ) investors are due to receive a payment of ₩450.00 per share on 3rd of April...
Analysis Article • Mar 27

We Think That There Are Some Issues For Cell Biotech (KOSDAQ:049960) Beyond Its Promising Earnings

Cell Biotech Co., Ltd.'s ( KOSDAQ:049960 ) healthy profit numbers didn't contain any surprises for investors. We...
Analysis Article • Aug 24

Shareholders Will Be Pleased With The Quality of Cell Biotech's (KOSDAQ:049960) Earnings

Cell Biotech Co., Ltd. ( KOSDAQ:049960 ) just reported healthy earnings but the stock price didn't move much. Investors...
Analysis Article • May 05

Factors Income Investors Should Consider Before Adding Cell Biotech Co., Ltd. (KOSDAQ:049960) To Their Portfolio

Is Cell Biotech Co., Ltd. ( KOSDAQ:049960 ) a good dividend stock? How can we tell? Dividend paying companies with...
Analysis Article • Mar 18

Is Cell Biotech Co., Ltd.'s (KOSDAQ:049960) Recent Price Movement Underpinned By Its Weak Fundamentals?

With its stock down 6.9% over the past three months, it is easy to disregard Cell Biotech (KOSDAQ:049960). It is...
Analysis Article • Feb 25

A Look At Cell Biotech's (KOSDAQ:049960) Share Price Returns

Statistically speaking, long term investing is a profitable endeavour. But that doesn't mean long term investors can...
Analysis Article • Feb 04

Key Things To Watch Out For If You Are After Cell Biotech Co., Ltd.'s (KOSDAQ:049960) 3.2% Dividend

Dividend paying stocks like Cell Biotech Co., Ltd. ( KOSDAQ:049960 ) tend to be popular with investors, and for good...
Analysis Article • Jan 14

Is Cell Biotech Co., Ltd. (KOSDAQ:049960) Popular Amongst Insiders?

If you want to know who really controls Cell Biotech Co., Ltd. ( KOSDAQ:049960 ), then you'll have to look at the...
Analysis Article • Dec 24

Don't Race Out To Buy Cell Biotech Co., Ltd. (KOSDAQ:049960) Just Because It's Going Ex-Dividend

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Cell Biotech...
Analysis Article • Dec 13

Cell Biotech Co., Ltd.'s (KOSDAQ:049960) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

Most readers would already be aware that Cell Biotech's (KOSDAQ:049960) stock increased significantly by 33% over the...
Analysis Article • Nov 18

Reflecting on Cell Biotech's (KOSDAQ:049960) Share Price Returns Over The Last Five Years

Cell Biotech Co., Ltd. (KOSDAQ:049960) shareholders should be happy to see the share price up 23% in the last quarter...

CEO

Myung-Jun Jung (68 yo)

no data
Tenure

Dr. Myung-Jun Jung serves as the Chief Executive Officer of Cell Biotech Co. Ltd and served as its President. Dr. Jung served as Team Leader of Central Research Center at Daesang Corporation and Professor...

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/16 20:53
End of Day Share Price 2026/08/14 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cell Biotech Co., Ltd. is covered by 8 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Young Ok KimDAOL Investment & Securities Co., Ltd.
Hyuk Jin YoonEugene Investment & Securities Co Ltd.
Sung Hwan ChoiKyobo Securities Co., Ltd